Novartis was cheered late last week by positive opinions for new hypertension treatment Exforge and blindness treatment Lucentis from the EU’s Committee for Medicinal Products for Human Use (CHMP), ...
ZURICH, June 21 (Reuters) - Swiss drugmaker Novartis has received final U.S. approval for its high blood pressure medicine Exforge. Novartis said on Thursday that the U.S. Food and Drug Administration ...
Novartis has received a major boost in the USA after regulators there gave their backing to two of the Swiss major’s combination high blood-pressure drugs which can now be used as first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback